Open AccessAtezolizumab and bevacizumab for hepatocellular carcinoma: mechanism, pharmacokinetics and future treatment strategies
Author(s) -
Xiufeng Liu,
Yi Lu,
Shukui Qin
Publication year - 2021
Publication title -
future oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.857
H-Index - 72
eISSN - 1744-8301
pISSN - 1479-6694
DOI - 10.2217/fon-2020-1290
Subject(s) - medicine , atezolizumab , bevacizumab , hepatocellular carcinoma , oncology , context (archaeology) , pharmacokinetics , liver transplantation , cancer , immunotherapy , transplantation , chemotherapy , nivolumab , paleontology , biology